Melanoma

15 competing products in clinical development for Melanoma.

Pipeline by Phase

Pre-clinical1

Phase 14

Phase 1/23

Phase 25

Phase 32

All Products (15)

Product	Company	Stage	Status	Hype
enfortumab vedotin + pembrolizumab	Astellas Pharma	Phase 2	Recruiting	42
Ipilimumab + Nivolumab	Ono Pharmaceutical	Phase 3	Completed	40
mRNA-4157 + Pembrolizumab	Merck	Phase 2	Active	39
YM155	Astellas Pharma	Phase 2	Completed	35
YM155 + Docetaxel	Astellas Pharma	Phase 2	Completed	35
AVT32-DRL_PB + Keytruda	Dr. Reddy's Laboratories	Phase 1	Recruiting	33
Tasisulam-sodium + Paclitaxel	Eli Lilly	Phase 3	Terminated	32
E7386 + Pembrolizumab + Lenvatinib	Eisai	Phase 1/2	Completed	32
Palonosetron	Eisai	Phase 1/2	Completed	32
DS-8273a + Nivolumab	Daiichi Sankyo	Phase 1	Completed	29
4-peptide melanoma vaccine + Ontak	Eisai	Phase 2	Terminated	27
PLX3397	Daiichi Sankyo	Pre-clinical	Completed	26
PLX3397 + Pembrolizumab	Daiichi Sankyo	Phase 1/2	Terminated	24
Decitabine + Pegylated Interferon Alpha-2b	Eisai	Phase 1	Terminated	21
Binimetinib Oral Tablet	Biotrial	Phase 1	UNKNOWN	15